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ÖZET
Ailesel hiperkolesterolemi (AH) arterlerde, ciltte ve ten-
donlarda aşırı kolesterol birikimine yol açan plazma ko-
lesterol yüksekliği ile karakterize otozomal dominant bir 
hastalıktır. Multipl ksantomlar nedeniyle cildiye poliklini-
ğine başvuran 34 yaşında bayan hasta için aterosklerotik 
hastalık açısından kardiyoloji konsültasyonu istendi. Has-
tanın herhangi bir kardiyak şikayeti yoktu. Koroner arter 
hastalığı (KAH) açısından risk faktörü olarak ailede erken 
KAH öyküsü mevcuttu. Fizik muayenede aort odakta 3/6 
sistolik üfürüm saptandı. Yapılan ekokardiyografide ciddi 
aort darlığı saptandı. Yapılan koroner anjiografide 3 koro-
ner damarın etkilendiği yaygın KAH saptandı. Biz bu ya-
zıda aort kapak tututulumu ve erken yaşta KAH nın eşlik 
ettiği heterozigos AH vakasını sunduk. Klin Deney Ar Derg 
2011; 2 (3): 308-311.
Anahtar kelimeler: Aort stenozu, koroner arter hastalığı, 
heterozigoz ailesel hiperlipidemi
ABSTRACT
Familial hypercholesterolemia (FH) is an autosomal domi-
nant disorder characterized by an elevation of LDL cho-
lesterol concentration in plasma leading to deposition of 
excess LDL-derived cholesterol in tendons, skin and arter-
ies. We studied a 34 year old woman who applied to der-
matology department due to multiple xanthomas. Cardi-
ac consulting was demanded by dermatology department 
to determine development of atherosclerosis. Patient had 
no risk factor and symptom related to cardiac problem, 
except  family  history  included  premature  coronary  ar-
tery disease (CAD). On examination systolic murmur was 
present in aortic area. Echocardiography showed valvular 
severe aortic stenosis with a good left ventricle systolic 
function and severe left ventricular hypertrophy. The cor-
onary arteriogram showed widespread CAD involving 3 
coronary vessels. We report a case of heterozygous FH 
type II a with premature CAD and aortic valve involve-
ment. J Clin Exp Invest 2011; 2 (3): 308-311.
Key  words:  Aortic  stenosis,  Coronary  artery  disease, 
Heterozygous familial hypercholesterolemia
INTRODUCTION
Familial hypercholesterolemia (FH) is a common 
autosomal dominant disorder caused by a mutation 
of the gene for the low-density lipoprotein (LDL) 
receptor.1 FH is usually a manifestation of increased 
levels of LDL cholesterol. Triglyceride levels are 
usually normal (type II a) or may be elevated (type 
IIb). Heterozygous FH (HeFH) (1:500) more fre-
quent than homozygous FH (HoFH) (1:1 000 000) 
in  general  population.2  FH  is  characterized  by  a 
high level of dominantly inherited hypercholester-
olemia, early appearance of cutaneous and tendon 
xanthomata, and increased risk of premature coro-
nary artery disease (CAD). Approximately 85% of 
males  and  50%  females  of  suffer  from  coronary 
events before 65 years old if they are not treated.3 
The rate of death from CAD among HeFH patients 
is several times higher than that among the general 
population.4 Hyper cholesterolemi affects not only 
the coronary artery, but also cardiac valve especially 
aortic valve and aortic root. Hyperlipidemia is asso-
ciated with degenerative aortic valve stenosis, and 
the disease resembles the inflammatory process of 
atherosclerosis.5  Hypercholesterolemia  constitute M. Şahin ve ark. Aortic valve involvement in hypercholesterolemia 309
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an important factor for etyologies of aortic stenosis 
in adult patients. We report a case of HeFH type II 
a with concomitant aortic stenosis and coronary ar-
tery disease involving three vessels.
CASE
A 34 year old female patient applied to dermatology 
department due to xanthomata. Cutaneous examina-
tion of the case revealed multiple eruptive yellow-
ish papules on the eyelids, trunk, and limbs. There 
were a few nodules covering the ankle joints and 
feet of patient. Yellowish papules were detected on 
the interdigital web space of the fingers (Figure 1). 
Mucosa, hair and nails were normal. Although the 
patient had no symptom related to cardiac problem 
cardiac consulting was demanded by dermatology 
department  to  determine  development  of  athero-
sclerosis. The patient had no risk factors for car-
diovascular disease except family history including 
death of her brother due to cardiac problem at the 
age of 30 during operation making for removal of 
multiple xanthomas and her father and uncle had 
coronary arter disease. However, her mother and 
other siblings didn’t have hyperlipidemia, thereby 
indicating HeFH in this patient. The patient’s blood 
pressure was 120/70 and pulse rate was regular (96 
beats/min). On cardiac examination, a systolic ejec-
tion murmur was heard in aortic area. Electrocar-
diography  (ECG)  revealed  normal  sinus  rhythm. 
Total cholesterol, triglyceride, HDL and LDL val-
ues were 493, 121, 24, and 442 mg/dL, respectively. 
Echocardiography demonstrated left ventricle hy-
pertrophy with normal systolic function, calcified 
and degenerative aortic valve with limited opening 
and 44 mm Hg mean gradient across the aortic valve 
(Figure 2). Aortic valve area was 1.2 cm2. The mi-
tral valve was looked high-echogenic and thickened 
but gradient was not obtained. Coronary anjiogra-
phy detected 60% occlusion at the proximal to Left 
Anterior Desending (LAD) before D1 branch, 40% 
occlusion at LAD mid-portion, 40% occlusion at 
Circumflex artery (Cx) mid-portion, and 100% oc-
clusion proximal to Right Coronary Artery (RCA). 
Retrograde flow of RCA was also present from Cx 
artery. Medical therapy was initiated for prevention 
of secondary coronary arter dissease and progretion 
of aortic stenosis.. Hypercholesterolemia was man-
aged with atorvastatin 80 mg per day. Because the 
patient had no symptom related to cardiac problem 
routine follow-up was advised.
Figure 1. Multiple xanthomata showed on fingers of hand and foot.M. Şahin ve ark. Aortic valve involvement in hypercholesterolemia 310
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Figure2. Gradient was obtained on the aortic valve
in life threatening aortic stenosis. Aortic stenosis is 
critical to the prognosis for most homoFH and some 
HeFH patients.9 HeFH patients who require surgi-
cal replacement, show additional risk factors suh 
as high blood pressure, smoking, and / or diabetes 
mellitus which all contribute to the aggravation of 
aortic valvular dysfunction result from underlying 
hypercholesterolemia.10  Our  patient  did  not  have 
additional risk factory and severe aortic stenosis. 
The most common cause of AS is slow progressive 
calcific degeneration, with an asymptomatic period 
which can last decade’s 10; therefore, it was thought 
that calcific AS resulted from aging and ‘wear and 
tear’ of the aortic valve.. Currently, this perception 
has been changing and some similarities have been 
found between the lesions of AS and atheromatous 
coronary artery disease 10 and calcific AS is being 
increasingly recognized as an inflammatory, ather-
omatous  and  potentially  modifiable  disease.  The 
young age of the patient indicates etiologic factors 
other than wear and tear due to ageing processes. In 
conclusion HeFH is a treatable and important cause 
of early CAD and valvular lesions, thus it is impor-
tant  that  this  condition  be  recognized,  diagnosed 
and treated in affected patients.
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